Protein Sequencing Market: By Products & Services, By Technology, By Application, By End-user ), and Region Forecast 2019-2030
Protein Sequencing Market size was valued at US$ 794.8 million in 2023 and is expected to reach US$ 962.1 million by 2030, at a significant CAGR of 5.5% from 2024-2030. Due to the increasing focus on target-based drug development activities by biotechnology and pharmaceutical companies and increasing demand for protein biomarkers in the process of drug development. Moreover, the growing application of protein sequencing technique for identifying novel peptides in human antibodies and antigens and advancements in clinical mass spectrometry and analytical techniques are driving the growth of the global market over the forecast timeframe.
This report studies global market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).
Study Period
2024-2030Base Year
2023CAGR
5.5%Largest Market
EuropeFastest Growing Market
North-America
Increasing focus on target based drug development activities is a key factor drive the global protein sequencing market. Due to the advancements in research, biotechnological and pharmaceutical companies are now focusing on the drug discovery and development based on target. The targeted receptor is made of protein for which we can determine the sequence of amino acids and then we can develop molecule for that particular sequence so that the drug can only bind to that particular site to prevent the adverse effects.
Moreover, increasing R&D expenditure of major pharmaceutical and biotechnology companies, decreasing cost of sequencing and increasing number of sequencing service providers are the factors believed to propel the global market over the forecast years.
North America accounted for larger revenue share in global protein sequencing market with significant CAGR. Owing to increase in focus on target-based drug development activities by biotechnology and pharmaceutical companies, rapid increase in research and development expenditure of prominent pharmaceutical and biotechnology companies and several public and private organizations, rising focus of players on structure-based drug design and the advent of technologically-advanced analytical methods used in protein sequencing.
Asia pacific protein sequencing market projected to grow at significant rate owing to increase in government funding for research in targeted based drug delivery and advanced sequencing infrastructure in research organizations.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 794.8 million |
|
Market Size in 2030 |
US$ 962.1 million |
|
Market CAGR |
5.5% |
|
By Products & Services |
|
|
By Application |
|
|
By Technology |
|
|
By End-user Industry |
|
|
By Region |
|
Download Free Sample Report
The protein sequencing market size was valued at US$ 794.8 million in 2023 and is projected to reach US$ 962.1 million by 2030, at a CAGR of 5.5% from 2024-2030
The Protein Sequencing Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The Protein Sequencing Market key players Agilent Technologies, Inc. (US), QIAGEN N.V. (Netherlands), Rapid Novor (Canada), Charles River Laboratories (US), Selvita (Poland), SGS S.A. (Switzerland), BGI Group (China), Thermo Fisher Scientific, Inc. (U.S), Bioinformatics Solutions Inc. (Canada), Proteome Factory AG (Germany), Shimadzu Corporation (Japan)
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
